MedTrace Logo

Efficacy of CompuFlo® Technology in Thoracic Epidural Space Identification

NCT05798754 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 276

Last updated 2023-04-05

No results posted yet for this study

Summary

The aim of this non inferiority trial is to assess the efficacy of CompuFlo® technology to identify the thoracic epidural space in relation to the gold standard loss of resistance technique.

Conditions

  • Thoracic Epidural Space Identification

Interventions

PROCEDURE

Loss of resistance (LOR) technique

The thoracic epidural space will be identified by the loss of resistance (LOR) technique

DEVICE

CompuFlo® technology

The thoracic epidural space will be identified by the CompuFlo® technology

Sponsors & Collaborators

  • General and Maternity Hospital of Athens Elena Venizelou

    lead OTHER

Principal Investigators

  • Konstantinos Stroumpoulis, PhD · General and Maternity Hopsital of Athens Helena Venizelou

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-30
Primary Completion
2025-01-31
Completion
2025-03-31
FDA Device
Yes

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05798754 on ClinicalTrials.gov